Lower Testosterone Levels With Luteinizing Hormone-Releasing Hormone Agonist Therapy Than With Surgical Castration: New Insights Attained by Mass Spectrometry-Reference-Cited by-同舟云学术

Lower Testosterone Levels With Luteinizing Hormone-Releasing Hormone Agonist Therapy Than With Surgical Castration: New Insights Attained by Mass Spectrometry

Published:2012-05 Issue:5 Volume:187 Page:1601-1607
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

van der Sluis Tim M.¹,Bui Hong N.²,Meuleman Eric J.H.¹,Heijboer Annemieke C.²,Hartman Jeroen F.³,van Adrichem Nick⁴,Boevé Egbert⁵,de Ronde Willem⁶,van Moorselaar R. Jeroen A.¹,Vis André N.¹

Affiliation:

1. Department of Urology, VU University Medical Centre, Amsterdam, The Netherlands

2. Department of Clinical Chemistry, VU University Medical Centre, Amsterdam, The Netherlands

3. Department of Urology, Rijnland Hospital, Leiderdorp, The Netherlands

4. Department of Urology, Meander Medical Centre, Amersfoort, The Netherlands

5. Department of Urology, Sint Franciscus Gasthuis, Rotterdam, The Netherlands

6. Department of Endocrinology, VU University Medical Centre, Amsterdam, The Netherlands

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Studies on prostatic cancer: I. The effect of castration, estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

2. Subcapsular castration for carcinoma of prostate;Riba;J Urol,1942

3. Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma;Kaisary;Br J Urol,1991

4. Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial;Vogelzang;Urology,1995

5. Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group;Soloway;Urology,1991

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical versus medical castration in the treatment of metastatic prostate cancer: A systematic review and meta-analysis;Journal of Clinical Urology;2023-11-22

2. Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy;The Journal of Clinical Endocrinology & Metabolism;2022-10-06

3. Testosterone analysis in castrated prostate cancer patients: suitability of the castration cut-off and analytical accuracy of the present-day clinical immunoassays;Clinical Chemistry and Laboratory Medicine (CCLM);2022-08-02

4. Testosterone analysis in prostate cancer patients;Advances in Clinical Chemistry;2022

5. Retrospective analysis of serum testosterone levels by LC-MS/MS in chemically castrated prostate cancer patients: Biological variation and analytical performance specifications;Clinica Chimica Acta;2021-10